Table 6. The quality-of-life assessment before and after the Novoglan treatment.

Ranking [scale 1 to 5]	Visit 1			Final Visit
	Count	Percent		Count	Percent
General pain/discomfort
None [1]	12	60		15	75
Slight [2]	5	25		5	25
Moderate [3]	3	15		0	0
Pain/discomfort during sexual activity
No pain [1]	1	5		13	65
Slight [2]	8	40		5	25
Moderate [3]	10	50		2	10
Severe [4]	1	5		0	0
Impact of usual activities
No problem doing usual activities [1]	19	95		19	95
Slight problems doing usual activities [2]	1	5		1	5
Anxiety/depression
Not anxious/depressed [1]	0	0		17	85
Slightly anxious/depressed [2]	16	80		3	15
Moderately anxious/depressed [3]	4	20		0	0